Stay updated on ALT-803 Plus Nivolumab in Lung Cancer Clinical Trial

Sign up to get notified when there's something new on the ALT-803 Plus Nivolumab in Lung Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ALT-803 Plus Nivolumab in Lung Cancer Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    1%
    Check dated 2025-03-03T23:00:25.000Z thumbnail image
  4. Check
    33 days ago
    No Change Detected
  5. Check
    40 days ago
    Change Detected
    Summary
    The web page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    1%
    Check dated 2025-02-10T15:46:46.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    The website has been updated from version 2.14.1 to 2.14.2.
    Difference
    0.1%
    Check dated 2025-02-03T10:58:02.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    The website has been updated from version 2.14.0 to 2.14.1.
    Difference
    0.1%
    Check dated 2025-01-20T02:04:43.000Z thumbnail image
  8. Check
    69 days ago
    Change Detected
    Summary
    The website has updated the 'type of intervention' feature from version v2.13.3 to v2.14.0, indicating a significant change in this functionality.
    Difference
    0.2%
    Check dated 2025-01-12T22:46:54.000Z thumbnail image
  9. Check
    98 days ago
    Change Detected
    Summary
    The website has been updated from version 2.13.2 to 2.13.3.
    Difference
    0.1%
    Check dated 2024-12-14T23:19:06.000Z thumbnail image

Stay in the know with updates to ALT-803 Plus Nivolumab in Lung Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ALT-803 Plus Nivolumab in Lung Cancer Clinical Trial page.